🇺🇸 FDA
Patent

US 11859021

Compounds for regulating trained immunity, and their methods of use

granted A61KA61K47/542A61K47/543

Quick answer

US patent 11859021 (Compounds for regulating trained immunity, and their methods of use) held by Trained Therapeutix Discovery, Inc. expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Trained Therapeutix Discovery, Inc.
Grant date
Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61K, A61K47/542, A61K47/543, A61K47/544, A61K47/554